Best Medical Oncologists for Targeted Therapy in Mumbai, India

This page lists 3 targeted therapy doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 3 targeted therapy doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Targeted Therapy doctors in Mumbai, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Targeted Therapy doctors

Image not available Featured

Dr. Jeyhan Dhabhar

MBBS, MD, DNB
Consultant — Medical Oncology and Hemato-Oncology · Specialty: Medical Oncologist and Hemato-Oncologist
Gleneagles Hospital, Mumbai Mumbai, India7+ Years experience
Why consider this doctor?
  • 7+ years of experience in Medical Oncologist and Hemato-Oncologist
  • Consultant Medical Oncologist and Hemato-Oncologist, Gleneagles Hospital, Mumbai, Parel — Present
  • Specialization in Precision Oncology and Cancer Genomics at Gleneagles Hospital, Mumbai — Present
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Targeted Therapy Planning and Delivery
  • Cancer Immunotherapy
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist and Hemato-Oncologist Experience: 7+ YearsHospital Affiliation: Gleneagles Hospital, MumbaiHospital accreditation: NABH, JCI
Image not available

Dr. Rohit Ramesh Pai

MBBS, MD in Internal Medicine, DM in Medical Oncology, MRCP (UK), MRCP (SCE), DNB in Medical Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Hospital Mumbai, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Medical Oncologist
  • Senior Consultant — Medical Oncology, Gleneagles Hospital, Mumbai
  • Consultant Medical Oncologist, Bombay Hospital, Mumbai
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Cancer Immunotherapy Planning and Delivery
  • Targeted Therapy Selection and Monitoring
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Gleneagles HospitalHospital accreditation: NABH, JCI
Image not available

Dr. Siddharth W. Turkar

DM, DNB, MBBS
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospitals Mumbai, India13+ Years experience
Why consider this doctor?
  • 13+ years of experience in Medical Oncologist
  • Consultant — Medical Oncology, Apollo Hospitals, Mumbai, Present
  • 13+ years of clinical experience in comprehensive cancer management
Expertise & Procedures
  • Chemotherapy for solid tumours
  • Neoadjuvant chemotherapy protocols
  • Adjuvant chemotherapy regimens
  • Palliative chemotherapy
  • Immune checkpoint inhibitor therapy
View all procedures →
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Apollo HospitalsHospital accreditation: JCI, NABH

Hospitals where these doctors practise

Gleneagles Global Hospitals (Global Hospitals)🇮🇳 Parel, Mumbai, India
Starting from$300

Gleneagles Global Hospitals (Global Hospitals)

Est. 1996
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation
Targeted TherapyMedical OncologyLiver TransplantCardiac Surgery
2+
Doctors for Targeted Therapy
4.6
183 reviews
450+
Beds
30+
Years Since Founded
Dr. Jeyhan DhabharDr. Rohit Ramesh Pai

Why consider treatment in India?

Many international patients consider India for liver & pancreatic cancer treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Targeted Therapy?

Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells. It is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.

Who may be considered?

Targeted Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

3 approaches available for this procedure:

Biomarker/Genomic Testing & Drug Selection

Essential First Step

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

Comprehensive Investigations

Estimated cost: $300 - $1,500

Tumor biopsy, IHC/FISH testing, next-generation sequencing (NGS) panel, liquid biopsy, complete blood count (CBC), liver and kidney function tests

Treatment / Procedure Estimate

Estimated cost in India: $300 - $2,000

Stay in India

Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: 0 days (outpatient)
Recovery period (outside hospital): ~1 day
Total stay: approx 3 days

Usually Included in Hospital Package

  • Oncologist consultation
  • Tissue/blood sample processing
  • Genomic report interpretation
  • Tumor board review

Usually Not Included

  • International shipping of external samples
  • Repeat biopsy if sample inadequate
  • Second confirmatory pathology opinion

Recovery and follow-up

Most patients tolerate targeted therapy on an outpatient or short-stay basis, with periodic monitoring for side effects such as fatigue, skin reactions, or organ toxicity; response is typically reassessed via imaging every 2-3 treatment cycles.

Risks

Potential risks include infusion reactions, cardiotoxicity, skin and gastrointestinal side effects, elevated liver enzymes, and, less commonly, resistance development requiring drug switch.

Alternatives

Depending on cancer type and stage, alternatives may include conventional chemotherapy, immunotherapy, hormonal therapy, radiation, or surgical resection, often used in combination with or instead of targeted therapy.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Histopathology and biopsy report
  • IHC/FISH biomarker results (HER2, ER/PR, etc.)
  • Next-generation sequencing (NGS) or mutation panel report
  • Recent CT/PET-CT/MRI imaging
  • Complete blood count and organ function tests
  • Prior treatment and chemotherapy history
  • Discharge summaries from previous hospitalizations
  • Current medication list

Patient information needed

  • Cancer type, stage, and site of primary tumor
  • Prior treatments including surgery, chemotherapy, radiation
  • Known genetic mutations or biomarker status if tested
  • Current performance status and comorbidities
  • Allergy history, especially to biologic drugs
  • Cardiac history if cardiotoxic drugs are anticipated
  • Insurance or budget considerations
  • Availability of a caregiver/companion during treatment

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Targeted Therapy) and procedure (Targeted Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Targeted Therapy in Mumbai, India

What is Liver & Pancreatic Cancer?
Liver cancer refers to malignant tumours that originate in the cells of the liver, most commonly hepatocellular carcinoma. Pancreatic cancer most frequently arises from the ductal cells of the pancreas (pancreatic ductal adenocarcinoma) and is known for its aggressive course and tendency to be detected late.
What are the symptoms and health risks of Liver & Pancreatic Cancer?
Common presentations of liver cancer include upper-right abdominal pain or fullness, unexplained weight loss, jaundice, fatigue, and abdominal swelling due to fluid accumulation (ascites). Pancreatic cancer may cause painless jaundice, mid-back or epigastric pain, new-onset diabetes, pale stools, dark urine, and significant unintentional weight loss. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis — a formal clinical and investigative assessment is always required.
How is Liver & Pancreatic Cancer diagnosed?
Diagnosis typically begins with blood tests including liver function panels and tumour markers such as AFP (alpha-fetoprotein) for liver cancer and CA 19-9 for pancreatic cancer, though these markers are not definitive on their own. Cross-sectional imaging — most commonly contrast-enhanced CT or MRI, and endoscopic ultrasound (EUS) for pancreatic lesions — is used to characterise the tumour and assess local spread. Staging (commonly BCLC staging for liver cancer and TNM staging for both) guides prognosis and treatment planning, and a tissue biopsy or cytological sample is usually obtained to confirm the diagnosis and tumour type.
How is Liver & Pancreatic Cancer treated?
Treatment options depend heavily on the stage at diagnosis, the patient's underlying liver function (Child-Pugh or ALBI score in liver cancer), overall fitness, and tumour biology. Surgical resection or liver transplantation may be appropriate for carefully selected liver cancer patients, while pancreatic cancer surgery (such as the Whipple procedure) is an option when the disease has not spread beyond the pancreas. For patients who are not surgical candidates, systemic therapies including chemotherapy, targeted therapy, and immunotherapy — all available through our directory — are central to management, alongside interventional options such as ablation or transarterial chemoembolisation (TACE) for liver tumours.
Can Liver & Pancreatic Cancer be treated without a procedure?
A substantial proportion of patients with liver or pancreatic cancer are managed without surgery, either because the disease is detected at a stage that precludes resection or because individual health factors make surgery high-risk. Systemic chemotherapy (for example, gemcitabine-based regimens for pancreatic cancer or sorafenib/lenvatinib for liver cancer), targeted therapy directed at specific molecular alterations, and immunotherapy with checkpoint inhibitors represent the main non-surgical treatment pillars. Palliative and supportive care — including pain management, nutritional support, and biliary stenting to relieve obstruction — is also a critical component of care for many patients and should be discussed with the treating team.
When is Targeted Therapy considered for Liver & Pancreatic Cancer?
Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Liver & Pancreatic Cancer?
These cancers are typically evaluated and managed by a medical oncologist with expertise in gastrointestinal or hepatobiliary malignancies, working within a multidisciplinary team that usually includes a hepatobiliary or pancreatic surgeon, a hepatologist, an interventional radiologist, and a gastroenterologist. For liver cancer in the setting of chronic liver disease, a hepatologist often plays a central role alongside the oncology team.
How do I choose a doctor for Liver & Pancreatic Cancer?
When choosing a provider, it is advisable to look for a centre with a dedicated hepatobiliary or gastrointestinal oncology multidisciplinary tumour board, demonstrated experience with the specific cancer type, access to clinical trials, and clear protocols for ongoing monitoring and palliative support. Asking about the volume of cases managed annually and the availability of interventional radiology and advanced endoscopy on site can also help you compare facilities meaningfully.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.